Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma

Clinical trial NCT03419572 · COMPLETED

Trial details

NCT number: NCT03419572
Sponsor: Ipsen
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma

Start date: 2018-04-24
Primary completion: 2022-05-19
Enrollment: 689

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.